COSM Stock Plunged: Here's What Happened

The Situation

Cosmos Health Inc (NASDAQ: COSM) shares – a global healthcare group with proprietary lines of nutraceuticals and distribution of pharmaceuticals – plunged on Tuesday after the company announced the results of its settlement agreement. As of 11:30 PM ET, Cosmos shares dropped by 11.18%.

The Explanation

Cosmos Health Inc recently changed its name from Cosmos Holdings Inc, after announcing a 1-for-25 reverse stock split on December 15. The reverse stock split took effect on December 16.

The company reached a settlement with the pursuant, Dr. Lee Ying Chiu, Herbert, citing the terms of the Share Exchange Agreement dated on June 17, 2021 in the Massive Treasure Limited acquisition. Dr. Lee was awarded 400,000,000 shares of common stock, as he originally had 800,000,000 shares.

See the $COSM chart performance here.

The Effect

Cosmos Health Inc stocks reportedly dropped as the company announced its settlement agreement with Dr. Lee. The investors reaction happened despite the company being able to settle the lawsuit instead of losing it.

Since investors can't know for sure how the company will perform moving forward, as it recently completed its reverse stock split, it is important to focus on Cosmos' business.

See full $COSM flow at: https://unusualwhales.com/stock/COSM/flow-overview

tastytrade logo+
Get the best broker for options trading and earn Unusual Whales discounted! in cash with an eligible account deposit at tastytrade. Get an Unusual Whales bonus when you deposit $2000. Offer expires 3/31/25. Certain restrictions, terms and conditions apply.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.